Recall Ledger

Fosfomycin Tromethamine Granules for Oral Solution recall (Cipla USA, Inc.)

DrugClass IIOngoing

Summary: Cipla USA, Inc. is recalling Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by: Cipla Ltd., Kurkumbh-413802, Maharashtra, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-579-67.. Reason: Failed Impurities/Degradation Specifications.

What is being recalled

Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by: Cipla Ltd., Kurkumbh-413802, Maharashtra, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-579-67.

Why

Failed Impurities/Degradation Specifications

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

USA Nationwide.

How to tell if yours is affected

Lot#: 5KA0405, Exp 12/31/2026.

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0014-2027
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusOngoing
Recall startedSeptember 18, 2026
ReportedOctober 14, 2026
CompanyCipla USA, Inc.
Company locationWarren, NJ, United States
Initiated byVoluntary: Firm initiated
QuantityN/A

More recalls from Cipla USA, Inc. · all drug recalls · recalls from September 2026

Official FDA record